Aspirin as preventive therapy in patients with asymptomatic vascular disease.
Berger
Jeffrey S
JS
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011322:Primary Prevention; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin